LCE provides reports for patient organisations to use in their advocacy and awareness efforts. The reports include key information learned from the LC Global Database on access to treatment and clinical trials and from the Global Patient Survey (GPS).
Europeans need access to equal, adequate care. Care includes treatment, clinical trials, personal support and credible information. The report makes seven recommendations to help improve care.
This report will help member organisations increase their understanding of HL, it’s treatment options, and the unmet needs of patients in Europe in terms of therapy access, clinical trials and quality of life.
This is the first LCE report focusing on a specific lymphoma subtype. The objective is to help our member organisations better understand the biology of CLL, available treatment options, and the unmet needs of patients in Europe in terms of therapy access, clinical trials and quality of life.
European Lymphoma Environment
This report illustrates the inequalities of access to care – medicines, treatments centres, clinical trials, etc. - around Europe, identifying patients’ unmet needs and highlighting the main issues and obstacles European patients experience along their journey.